These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36412158)

  • 1. [Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment].
    Kolykhalov IV; Androsova LV; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):59-66. PubMed ID: 36412158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].
    Gavrilova SI; Kolykhalov IV; Ponomareva EV; Fedorova YB; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):45-53. PubMed ID: 29927403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment.
    Lee SH; Choi BY; Kim JH; Kho AR; Sohn M; Song HK; Choi HC; Suh SW
    Brain Res; 2017 Jan; 1654(Pt A):66-76. PubMed ID: 27765578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of cluster analysis and logistic regression for assessing the risk of Alzheimer's disease in patients with mild cognitive impairment, amnestic type].
    Simonov AN; Klyushnik TP; Androsova LV; Mikhailova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12):40-43. PubMed ID: 30698559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.
    Peng GP; Feng Z; He FP; Chen ZQ; Liu XY; Liu P; Luo BY
    CNS Neurosci Ther; 2015 Jan; 21(1):15-22. PubMed ID: 25146658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of amnestic mild cognitive impairment: clinical and immunological correlations].
    Ponomareva EV; Krinsky SA; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):16-22. PubMed ID: 34870909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers].
    Alesenko AV; Gavrilova SI; Gutner UA; Lebedeva AO; Shupik MA; Kolykhalov IV; Ponomareva EV; Selezneva ND; Fedorova YB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):21-27. PubMed ID: 28745666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    Brown JM; Lansdall CJ; Wiggins J; Dawson KE; Hunter K; Rowe JB; Parker RA
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1045-1051. PubMed ID: 28912299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological variants of amnestic mild cognitive impairment].
    Malashenkova IK; Krynskiy SA; Hailov NA; Ogurtsov DP; Chekulaeva EI; Ponomareva EV; Gavrilova SI; Didkovsky NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):60-68. PubMed ID: 33244960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Scarabino D; Broggio E; Gambina G; Corbo RM
    Exp Gerontol; 2017 Nov; 98():143-147. PubMed ID: 28827085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.
    Senturk G; Bilgic B; Arslan AB; Bayram A; Hanagasi H; Gurvit H; Emre M
    Int Psychogeriatr; 2017 Feb; 29(2):293-302. PubMed ID: 27780496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
    Martínez-Florez JF; Osorio JD; Cediel JC; Rivas JC; Granados-Sánchez AM; López-Peláez J; Jaramillo T; Cardona JF
    J Alzheimers Dis; 2021; 81(2):729-742. PubMed ID: 33814438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in cognitive ability and hippocampal volume between Alzheimer's disease, amnestic mild cognitive impairment, and healthy control groups, and their correlation.
    Choi MH; Kim HS; Gim SY; Kim WR; Mun KR; Tack GR; Lee B; Choi YC; Kim HJ; Hong SH; Lim DW; Chung SC
    Neurosci Lett; 2016 May; 620():115-20. PubMed ID: 27019036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.